Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002873 · ClinicalTrials.gov registry record · Phase 1
Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer
A Phase 1 study of Breast Cancer, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Study locations
NCT00002873: Completed Phase 1 study of Breast Cancer, sponsored by Radiation Therapy Oncology Group.
NCT00002873 is a Phase 1 study of Breast Cancer that has completed, run by Radiation Therapy Oncology Group. The trial reports 20 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002873, a Phase 1 study of Breast Cancer, has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20
- Study locations
Study Summary
RATIONALE: Radiation therapy may kill any tumor cells remaining after surgery. PURPOSE: Phase I/II trial to study the effectiveness of brachytherapy in treating women who have stage I or stage II breast cancer.
Conditions Studied
Interventions
- RADIATION brachytherapy
Study Locations (20)
California
- Providence Saint Joseph Medical Center - Burbank - Burbank
- Mount Diablo Medical Center - Concord
- Beckman Research Institute, City of Hope - Duarte
- California Cancer Center - Fresno
- Saint Agnes Cancer Center - Fresno
- Glendale Memorial Hospital and Health Center - Glendale
- Sutter Health Western Division Cancer Research Group - Greenbrae
- Loma Linda University Medical Center - Loma Linda
- Veterans Affairs Medical Center - Long Beach - Long Beach
- Kaiser Permanente Medical Center - Los Angeles - Los Angeles
- USC/Norris Comprehensive Cancer Center - Los Angeles
Alabama
- Veterans Affairs Medical Center - Birmingham - Birmingham
- University of Alabama Comprehensive Cancer Center - Birmingham
- Huntsville Hospital System - Huntsville
- Urology Associates - Mobile AL - Mobile
- MBCCOP - University of South Alabama - Mobile
- Alabama Oncology, LLC - Montgomery
- Radiation Oncology Associates of West Alabama - Tuscallosa
Alaska
- Providence Cancer Therapy Center - Anchorage
Arizona
- Arizona Cancer Center - Tucson
Trial Details
| Field | Value |
|---|---|
| Start Date | 1997-05 |
| Phase | Phase 1 |
What the finished NCT00002873 record still lists
NCT00002873 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 1 intervention - of which brachytherapy is the first listed.
NCT00002873 names 20 study sites across 4 states, led by California, Alabama, Alaska.
Frequently Asked Questions
What is clinical trial NCT00002873 about?
NCT00002873 is a clinical study titled "Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer". RATIONALE: Radiation therapy may kill any tumor cells remaining after surgery. PURPOSE: Phase I/II trial to study the effectiveness of brachytherapy in treating women who have stage I or stage II breast cancer.
What is the current status of trial NCT00002873?
This trial is currently completed. It is a Phase 1 study. The study started on 1997-05.
What conditions does trial NCT00002873 study?
This clinical trial studies the following conditions: Breast Cancer.
What interventions are being tested in trial NCT00002873?
The interventions under investigation include: brachytherapy (RADIATION).
Who is sponsoring clinical trial NCT00002873?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00002873 being conducted?
This trial has 20 study locations across Alabama, Alaska, Arizona, California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
VS-6766+Abema+Fulv in Met HR+/HER- BC
RECRUITING · Phase 1
-
KK-LC-1 TCR-T Cell Therapy for Gastric, Breast, Cervical, and Lung Cancer
RECRUITING · Phase 1
-
Focused Ultrasound and Gemcitabine in Breast Cancer
RECRUITING · Phase 1
-
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RECRUITING · Phase 1
-
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
RECRUITING · Phase 1
-
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia